Enterprise Value
$303.24 M
-$7.45 M-2.40%
4 min ago
Summary
- As of February 28, 2025, LXRX enterprise value is $303.24 million, with a fall of -$7.45 million (-2.40%) during the most recent trading day.
- Over the past year, LXRX enterprise value has dropped by -$424.51 million (-58.33%).
- LXRX enterprise value is now -86.21% below its all-time high of $2.20 billion.
Performance
LXRX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
LXRX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -2.4% | -3.0% | -3.0% |
| 1 m1 month | -25.4% | -30.4% | -30.4% |
| 3 m3 months | -16.4% | -20.0% | -20.0% |
| 6 m6 months | -56.1% | -62.2% | -62.2% |
| ytdytd | -7.2% | -9.1% | -9.1% |
| 1 y1 year | -58.3% | -63.3% | -75.1% |
| 5 y5 years | -40.0% | -19.9% | -76.5% |
LXRX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -27.4% | $303 M | at low | |
| 3 m | 3-month | $425 M | -28.6% | $303 M | at low |
| 6 m | 6-month | $815 M | -62.8% | $303 M | at low |
| 1 y | 1-year | $933 M | -67.5% | $303 M | at low |
| 3 y | 3-year | $965 M | -68.6% | $162 M | +87.2% |
| 5 y | 5-year | $1.17 B | -74.1% | $92 M | +229.7% |
| alltime | all time | $2.20 B | -86.2% | $55 M | +451.4% |
Lexicon Pharmaceuticals Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $303.24 M(-7.2%) |
| 2024 | $326.92 M(-27.1%) |
| 2023 | $448.54 M(+21.4%) |
| 2022 | $369.42 M(-29.6%) |
| 2021 | $524.95 M(+41.7%) |
| 2020 | $370.46 M(-43.1%) |
| 2019 | $650.65 M(-25.0%) |
| 2018 | $867.96 M(-29.3%) |
| 2017 | $1.23 B(-18.0%) |
| 2016 | $1.50 B(+17.0%) |
| 2015 | $1.28 B(+103.2%) |
| 2014 | $629.57 M(-30.7%) |
| 2013 | $908.74 M(-19.3%) |
| Date | Value |
|---|---|
| 2012 | $1.13 B(+145.7%) |
| 2011 | $458.01 M(-2.0%) |
| 2010 | $467.14 M(+76.2%) |
| 2009 | $265.11 M(+94.7%) |
| 2008 | $136.13 M(-67.8%) |
| 2007 | $422.92 M(+49.5%) |
| 2006 | $282.83 M(+12.9%) |
| 2005 | $250.59 M(-51.4%) |
| 2004 | $515.71 M(+49.7%) |
| 2003 | $344.48 M(+62.2%) |
| 2002 | $212.33 M(-63.6%) |
| 2001 | $583.98 M(-23.9%) |
| 2000 | $767.56 M |
FAQ
- What is Lexicon Pharmaceuticals enterprise value?
- What is the all time high enterprise value for Lexicon Pharmaceuticals?
- What is LXRX enterprise value year-to-date change?
- What is Lexicon Pharmaceuticals enterprise value year-on-year change?
What is Lexicon Pharmaceuticals enterprise value?
The current enterprise value of LXRX is $303.24 M
What is the all time high enterprise value for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high enterprise value is $2.20 B
What is LXRX enterprise value year-to-date change?
Lexicon Pharmaceuticals enterprise value has changed by -$23.68 M (-7.24%) since the beginning of the year
What is Lexicon Pharmaceuticals enterprise value year-on-year change?
Over the past year, LXRX enterprise value has changed by -$424.51 M (-58.33%)